Plain language summaries

We understand that reports on Clinical Trial studies and outcomes can be difficult to understand, making them virtually inaccessible to the general public.

Kyowa Kirin is committed to developing Plain Language Summaries of Clinical Trials we are involved in, aiming to make them easy to read and comprehend. We hope this is helpful.

We are working to build our library and will share more Summaries as quickly as possible.

This study was done to compare burosumab against standard of care (a combination...

This study was done to compare burosumab against standard of care (a combination of oral phosphate and active vitamin D) for X-Linked Hypophosphatemia (XLH).
July 1, 2014
  • Disease/Condition: 
    XLH
  • Study Phase: 4
  • Drug Name: burosumab (CRYSVITA)
  • Language: English
  • Location: California

This study was done to learn if burosumab worked and to understand its safety in...

This study was done to learn if burosumab worked and to understand its safety in children with X-linked hypophosphatemia
July 1, 2014
  • Disease/Condition: 
    XLH
  • Study Phase: 4
  • Drug Name: burosumab (CRYSVITA)
  • Language: French

Dit onderzoek werd uitgevoerd om na te gaan of burosumab werkte en om de veiligh...

Dit onderzoek werd uitgevoerd om na te gaan of burosumab werkte en om de veiligheid ervan bij kinderen met X-gebonden hypofosfatemie te begrijpen
July 1, 2014
  • Disease/Condition: 
    XLH
  • Study Phase: 4
  • Drug Name: burosumab (CRYSVITA)
  • Language: Dutch
  • Location: Connecticut

This study was done to compare burosumab against standard of care (a combination...

This study was done to compare burosumab against standard of care (a combination of oral phosphate and active vitamin D) for X-Linked Hypophosphatemia (XLH)
September 1, 2016
  • Disease/Condition: 
    XLH
  • Drug Name: burosumab (CRYSVITA)
  • Language: English
  • Location: California